Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
Conditions
Interventions
Intervention1: 2% lidocaine solution through a portable iontophoresis device: Application of a 2% lidocaine solution using a portable iontophoresis device to reduce pain in adult cancer patients 10 mi
Sponsors
Research Institute and hospital
Eligibility
Inclusion criteria
Inclusion criteria: Adult cancer patients aged 18 years and older coming for IV cannulation
Exclusion criteria
Exclusion criteria: clinical evidence of dehydration, lidocaine allergy, decreased mental status, or patients with pacemaker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcome of the study will help to establish iontophoresis technique as a means of providing dermal anesthesia, which will be non-invasive, cost-effective and will have shorter onset time period of drug delivery as compared to the EMLA cream.Timepoint: The onset time taken by EMLA cream to provide therapeutic anesthesia is approximately 45-60 minutes. So, there is a strong need to reduce this onset time. Hence in the present work, by using iontophoresis technique, lignocaine will be delivered in shorter time (5-10minutes) thereby reducing the onset time and cost. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of Pain level during cannulationTimepoint: Two Times with iontophoresis or EMLA & without iontophoresis device or EMLA | — |
Countries
India
Contacts
Public ContactDr Sushma Bhatnagar
ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI
Outcome results
None listed